India’s pharmaceutical industry is a global powerhouse, contributing billions of dollars annually and employing millions of people. However, the regulatory landscape governing this thriving sector often feels like a maze to drug marketers. Governed primarily by the Drugs and…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
